Glucagon-like peptide-1 (GLP-1) agonists, also called GLP-1 receptor agonists or incretin mimetics, are a class of prescription medications used primarily to manage type 2 diabetes mellitus and, in some formulations, obesity
These drugs aid glycemic control through multiple mechanisms like enhancing insulin secretion, suppressing glucagon levels, and reducing appetite to induce weight loss
Most insurers cover these medications for type 2 diabetes but have stricter requirements for weight loss
Perhaps the most overlooked benefit is sustainability
Whether you are currently using semaglutide or considering it as a treatment option, this comprehensive guide will provide valuable insights into managing semaglutide-induced rashes
Audiobook: MP3 (DRM-free)